BioInnova

What BioInnova does

BioInnova Soluções em Biotecnologia is a Brasília-based contract laboratory founded in 2019 that provides in vitro safety, efficacy, toxicology, and regulatory assessment services for products intended for the Brazilian market. The company runs a single ISO 7 certified facility in Águas Claras (Brasília) staffed by five veterinary doctors with master's and doctoral degrees in Animal Sciences, Genomic Sciences and Biotechnology, and Alternative Methods to Animal Use. Services are organized around six modules: oral toxicity prediction (OECD GD 129), in vitro micronucleus genotoxicity testing (OECD TG 487), Ames mutagenicity testing (OECD TG 471), MTT cytotoxicity testing, custom efficacy testing using flow cytometry or spectrophotometry with statistical analysis and optional scientific article publication, and regulatory affairs consulting for ANVISA and MAPA product registrations including dossier preparation.

The technology stack is built on standardized international OECD test guidelines rather than proprietary IP; the company sells expert execution of validated cell-culture assays combined with Brazilian regulatory submission support. The go-to-market is sales-led and direct: prospects reach BioInnova via its website, Instagram, LinkedIn, WhatsApp Business, phone, or email, and each engagement is quote-based and tailored to the client's specific testing needs rather than offered as a recurring SaaS or subscription. Target customers span five verticals — pharmaceuticals and cosmetics as primary segments, with veterinary/biologicals, food and supplements, and biomaterials as secondary — all of which face increasing pressure to reduce or eliminate animal testing and require OECD-compliant documentation for ANVISA or MAPA registration.

BioInnova is privately held, has no disclosed investors or funding history, and reports between 1 and 10 employees. Revenue is generated entirely from professional services fees on a project-by-project basis, and no public pricing is available. The company does not disclose customer names, ARR, or contract values, and no information is available on partnerships, M&A activity, patents, or awards. BioInnova appears to be an early-stage operating business competing in Brazil's regulatory testing market on the basis of its specialized team, ISO 7 certified lab, and bundled regulatory consulting, rather than on scale, proprietary technology, or external capital.

Name

BioInnova

Legal name

BioInnova Soluções em Biotecnologia

Website

https://bioinnova.com.br

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

BioInnova is a Brasília-based contract laboratory founded in 2019 that performs OECD-compliant in vitro safety, efficacy, and toxicology testing, plus ANVISA and MAPA regulatory consulting, for pharmaceutical, cosmetics, veterinary, food, and biomaterials companies in Brazil.

Ownership category

akta.pro rank

Product category

Contract Laboratory Testing / In Vitro Safety Assessment

NAICS

Testing Laboratories and Services (54138)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

In Vitro Toxicology (Cell-based/Organ-on-chip) (HLAGAFAJ)

akta.pro secondary industries

Genetic Toxicology (Ames/Micronucleus/Comet) (HLAGAFAE), Cell-Based & Potency Assays (Bioassays) (HLAGADAH)

Keywords

• In vitro toxicology testing
• Genotoxicity assay services
• Mutagenicity testing laboratory
• Regulatory consulting bioscience
• Alternative animal testing

Headquarters

HQ city

Brasília

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Laboratory Testing Services: Provides contract laboratory testing services for safety (toxicity, genotoxicity, mutagenicity, cytotoxicity) and efficacy testing of products. Services are customized per client and product requirements. Pricing is quote-based, likely project/contract-based rather than recurring.
2. Regulatory Affairs Consulting: Consulting services for regulatory registration of pharmaceutical and biological products with ANVISA and MAPA. Includes dossier preparation and documentation analysis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

BioInnova provides in vitro safety, efficacy, toxicology, and regulatory assessment services for the pharmaceutical, cosmetics, veterinary, and chemical industries. The company conducts genotoxicity, mutagenicity, cytotoxicity, oral toxicity, and efficacy assays in an ISO 7 certified laboratory, applying OECD guideline-compliant alternative methods that do not require animal testing. It also advises clients on regulatory matters related to test submissions.

Product overview

BioInnova is a biotechnology services company offering a portfolio of in vitro testing services without animal testing. The core offerings include six distinct service modules: oral toxicity prediction (OECD GD 129), genotoxicity via micronucleus testing (OECD TG 487), mutagenicity via Ames test (OECD TG 471), cytotoxicity via MTT assay, customized efficacy testing with flow cytometry/spectrophotometry, and regulatory consulting for ANVISA and MAPA submissions. All services follow international OECD guidelines and are conducted in an ISO 7 certified laboratory.

Differentiator

Problem solved

Functional benefit

Products and services

• Predição da Toxicidade Oral (Oral Toxicity Prediction)
• Genotoxicidade - Teste de Micronúcleos in vitro (Genotoxicity - In Vitro Micronucleus Test)
• Mutagenicidade - Teste de Ames (Mutagenicity - Ames Test)
• Citotoxicidade - Teste MTT (Cytotoxicity - MTT Assay)
• Testes de Eficácia (Efficacy Testing)
• Assuntos Regulatórios (Regulatory Affairs Consulting)

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators2 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• Institute for In Vitro Sciences (IIVS): Non-profit reference laboratory focused exclusively on in vitro toxicity testing and alternatives to animal testing. Closely comparable to BioInnova in mission, methodology (OECD-aligned assays), and target clientele (cosmetics, pharmaceutical, chemical).
• MB Research Labs: US-based contract research organization offering in vitro toxicology, genotoxicity (Ames, micronucleus), and cytotoxicity assays. Very similar service mix to BioInnova, supplying regulated industries with OECD-compliant safety data.
• Toxys: Dutch CRO specializing in in vitro toxicology and genotoxicity testing, including Ames and micronucleus services. Directly comparable as a niche alternative-methods laboratory with similar assay catalog and regulated client base.
• Xenometrix AG: Swiss-based in vitro genotoxicity and toxicology CRO offering Ames, micronucleus, and related OECD-aligned assays. Closely comparable to BioInnova's genetic toxicology service line in both technology and customer profile.
• Vitroscreen: Italian CRO offering in vitro safety and efficacy testing using OECD-validated cell-based assays across cosmetics, pharma, and chemicals. Directly comparable service catalog and customer set to BioInnova's.
• Cyprotex (an Evotec company): Contract research organization specializing in in vitro ADME and toxicology assays for chemical, cosmetic, and pharmaceutical risk assessment. Comparable to BioInnova in cell-based safety science and regulated client focus.

Broad incumbents

• Eurofins Scientific: Global testing services group with an extensive in vitro toxicology, genotoxicity, and product-safety portfolio. Overlaps directly with BioInnova's offerings but operates at vastly larger scale and breadth across geographies, including LATAM.
• Charles River Laboratories: Large preclinical CRO with safety assessment including in vitro toxicology and genetic toxicology arms. Comparable across assay menu but offers far broader integrated drug-development and manufacturing services that BioInnova does not.
• Inotiv: Preclinical CRO providing in vitro toxicology, genetic toxicology, and safety assessment services as part of a broader research-models and DMPK portfolio. Competes with BioInnova on individual assays while bundling a much wider solution set.
• SGS: Global testing, inspection and certification firm with a life-sciences safety-assessment practice including OECD-aligned in vitro assays. Overlaps with BioInnova's services for cosmetics, pharma, and consumer-product clients.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInbr.linkedin.com/company/bioinnova-solu%C3%A7%C3%B5es-em-biotecnologia
• Instagraminstagram.com/bioinnovalab

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioInnova